PGK1 serves as a core gene in tumour metabolism, particularly glycolysis, and plays a determining role in evaluating immune therapy response, as indicated by the over‐expression of PGK1 in immunosuppressive cells and significant correlations to the expression of ICMs.31 This evidence concerns the gene PGK1 and neoplasm.